LifeScan Global Corp., the glucose-monitor maker backed by private equity firm Platinum Equity, filed for
- The plan has the backing of 97% of the company’s secured creditors. It will see debt cut by more than 75% and will allow the company to continue operating normally during its Chapter 11 case.
- Alongside $667 million of financial debt, LifeScan reported more than $1 billion of outstanding rebate claims on its balance sheet. These originated from agreements with US pharmacy benefit managers, state Medicaid entities, and ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.